Clinical Response in Subjects with Psoriatic Arthritis Following One Year of Treatment with Brodalumab, an Anti-Interleukin-17 Receptor Antibody Genovese, M. C., Mease, P., Greenwald, M. W., Ritchlin, C. T., Beaulieu, A., Deodhar, A. A., Newmark, R., Feng, J., Erondu, N., Nirula, A. WILEY-BLACKWELL. 2014: S687

View details for Web of Science ID 000344384903181